GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Sight Sciences Inc.
Sight Sciences is a medical device company that treats glaucoma and ocular surface diseases. Its stock price reflects its struggle to gain medical acceptance and insurance coverage for its innovative, but expensive, technologies.
Share prices of companies in the market segment - Specialized medical equipment
Sight Sciences is a medical device company developing and commercializing technologies for the treatment of glaucoma and dry eye disease. We classified it as a "Specialized Medical Equipment" company. The chart below shows how investors value innovative ophthalmology solutions.
Broad Market Index - GURU.Markets
Sight Sciences is a medical device company developing and commercializing technologies for the treatment of glaucoma and dry eye disease. As a component of the GURU.Markets index, it represents the ophthalmology innovation sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
SGHT - Daily change in the company's share price Sight Sciences Inc.
The volatility of Sight Sciences, a company specializing in eye diseases, is measured by change_co. It reflects its sensitivity to regulatory decisions and the commercial success of its products. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Sight Sciences, Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to SGHT, which focuses on glaucoma treatment, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Sight Sciences develops medical devices for the treatment of glaucoma and dry eye disease. This innovative ophthalmology company's shares are responding to clinical successes and the acceptance of its technologies by doctors. Its story exemplifies the medtech sector's contribution to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Sight Sciences Inc.
Sight Sciences, Inc.'s year-over-year performance tells the story of its minimally invasive technologies for treating glaucoma and dry eye. Its trailing 12-month market cap reflects how successfully the company convinces physicians and insurance companies of the benefits of its OMNI and TearCare systems, which is key to its commercial success.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Sight Sciences, Inc. is a medical device company developing devices for the treatment of glaucoma and ocular surface diseases. Its innovative products target a massive market. The chart below shows how its rapid growth, commercialization efforts, and ophthalmology competition are impacting its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sight Sciences, with its glaucoma treatment devices, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of technology adoption by doctors and the insurance system. The chart reflects the potential of this breakthrough technology in the vast ophthalmology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Sight Sciences Inc.
Sight Sciences' stock price dynamics reflect the company's operational momentum. Monthly price changes are driven by news about clinical trials, regulatory approvals, and, most importantly, sales reports for its innovative systems for treating glaucoma and dry eye disease. The chart shows investor reaction to the speed of commercialization of these technologies.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Sight Sciences develops and markets medical devices for the treatment of glaucoma and dry eye diseases. The ophthalmology sector is growing due to an aging population. The industry dynamics chart demonstrates the general interest in new, minimally invasive technologies. Sight Sciences strives to make its products the new standard of care in this large and competitive market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Sight Sciences, Inc. is a medical device company focused on treating the most common causes of blindness: glaucoma and dry eye disease. Its business depends on the adoption of its technologies. The broader market graph serves as a backdrop to assess the extent to which its innovative minimally invasive devices have gained market share in ophthalmology.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Sight Sciences Inc.
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and dry eye disease. Its weekly stock price is driven by the pace of adoption of its technologies by surgeons and recent changes in insurance reimbursement policies, which have created challenges for the company.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Sight Sciences develops devices to treat glaucoma and dry eye disease. The company's success depends on ophthalmologists adopting its technologies and securing insurance coverage. Compare its weekly performance to the sector to understand whether its narrow focus makes it more or less volatile than its competitors.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Sight Sciences is a manufacturer of ophthalmological equipment. Demand for its products is less dependent on economic cycles, making the sector "defensive." The chart will show whether the company's shares are truly less volatile than the market.
Market capitalization of the company, segment and market as a whole
SGHT - Market capitalization of the company Sight Sciences Inc.
Sight Sciences' market capitalization dynamics reflect its focus on developing and commercializing devices for the treatment of glaucoma and dry eye diseases. Its chart shows how investors view its innovative products and their potential to change the standard of care in ophthalmology, despite intense competition.
SGHT - Share of the company's market capitalization Sight Sciences Inc. within the market segment - Specialized medical equipment
Sight Sciences is a medical device company developing and commercializing devices for the treatment of glaucoma and dry eye disease. Its market share is growing thanks to its innovative products. The chart shows how the company strives to offer new, minimally invasive approaches to treating common ophthalmological diseases.
Market capitalization of the market segment - Specialized medical equipment
Here's a chart showing the market capitalization of the ophthalmology equipment sector. Sight Sciences is a company focused on treating glaucoma and dry eye disease. The growth you see in this market is driven by an aging population. Sight Sciences offers innovative, minimally invasive solutions for these common conditions.
Market capitalization of all companies included in a broad market index - GURU.Markets
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and dry eye syndrome. Its market capitalization is driven by new approaches to ophthalmology. The chart below shows the economic weight of companies solving common vision problems.
Book value capitalization of the company, segment and market as a whole
SGHT - Book value capitalization of the company Sight Sciences Inc.
Sight Sciences' foundation is its intellectual property and manufacturing assets for creating minimally invasive devices for the treatment of glaucoma and dry eye disease. This chart tells the story of a medical company investing in the commercialization of its unique technologies to change the standard of care in ophthalmology.
SGHT - Share of the company's book capitalization Sight Sciences Inc. within the market segment - Specialized medical equipment
Sight Sciences develops devices for the treatment of eye diseases. The chart shows its share of real assets. These include its manufacturing facilities, where they create microinvasive implants for glaucoma treatment and dry eye therapy systems.
Market segment balance sheet capitalization - Specialized medical equipment
Sight Sciences produces devices for the treatment of glaucoma. Its business requires investment in production, making it capital-intensive. The chart below shows the total value of assets in the medical device sector, providing a backdrop for assessing its base.
Book value of all companies included in the broad market index - GURU.Markets
Sight Sciences develops and manufactures medical devices for the treatment of glaucoma and dry eye disease. The company's assets include its manufacturing facilities. Its stake in BCap_All represents its physical scale in creating innovative solutions for some of the most common ophthalmological problems.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Sight Sciences Inc.
Sight Sciences is a medical technology company. Its valuation fell below book value following an unfavorable coverage decision for its core product. The chart shows how regulatory risks could erode the innovation premium.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Sight Sciences is a medical technology company developing devices to treat glaucoma and dry eye diseases. Its value is driven by innovative products and patents. The chart shows the premium investors pay for its technological leadership in ophthalmology.
Market to book capitalization ratio for the market as a whole
Sight Sciences develops and markets devices for the treatment of glaucoma and ocular surface diseases. It is a medical technology company with innovative products. This chart helps estimate the market premium for developing new treatment standards in ophthalmology over and above the value of the company's tangible assets.
Debts of the company, segment and market as a whole
SGHT - Company debts Sight Sciences Inc.
Sight Sciences, a company developing medical devices for the treatment of glaucoma and dry eye diseases, is using the capital to commercialize its products. Its debt strategy is focused on expanding its sales team, marketing to ophthalmologists, and conducting research to validate the long-term effectiveness of its technologies.
Market segment debts - Specialized medical equipment
Sight Sciences develops and manufactures medical devices for the treatment of glaucoma and ocular surface diseases. This is an innovative sector of ophthalmology, requiring investment in clinical research and marketing. This chart shows how the company is funding the commercialization of its technologies, aiming to offer new standards of treatment.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Sight Sciences Inc.
Sight Sciences develops medical devices for the treatment of glaucoma and dry eye diseases. Bringing innovative medical technology products to market and promoting them requires significant investment. This chart shows the company's use of debt to finance its commercial strategy, which is an indicator of its financial risk.
Market segment debt to market segment book capitalization - Specialized medical equipment
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and ocular surface diseases. This chart shows debt trends in the medical device sector. It helps assess how the company finances the launch of its innovative products and how its debt strategy compares to other ophthalmology companies.
Debt to book value of all companies in the market
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and dry eye diseases. Medical technologies require significant investment in clinical research and marketing. This chart shows general trends in the credit market. It helps understand whether the company prefers to finance its growth with equity or uses debt to accelerate commercialization.
P/E of the company, segment and market as a whole
P/E - Sight Sciences Inc.
Sight Sciences is an ophthalmology company developing and commercializing devices for the treatment of glaucoma and dry eye diseases. This chart shows how the market values its innovative products. This assessment is based on expectations of sales growth and widespread adoption of its technologies by ophthalmic surgeons.
P/E of the market segment - Specialized medical equipment
This industry chart for medical device manufacturers serves as a benchmark for Sight Sciences. It reflects the generally high expectations for medical innovation. Comparison with it helps understand whether Sight Sciences' technologies for treating glaucoma and dry eye disease are considered more or less disruptive than those of other ophthalmology companies.
P/E of the market as a whole
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and dry eye diseases. The company is creating new markets for its technologies. This chart of overall sentiment in the medical device sector shows whether investors are willing to fund costly efforts to educate physicians and change treatment standards.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Sight Sciences Inc.
Sight Sciences is a medical technology company developing solutions for glaucoma and dry eye diseases. This chart shows the expectations for its innovative products. The assessment depends on the speed of their adoption by ophthalmologists, sales volumes, and sufficient insurance reimbursement, which is a key success factor in the medical device sector.
%20P%2FE%20Sight%20Sciences%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Sight-Sciences-Inc.&v=1772644578358 "Chart of the company's future (projected) P/E Sight Sciences Inc.")
Future (projected) P/E of the market segment - Specialized medical equipment
Sight Sciences is a medical device company focused on developing treatments for glaucoma and dry eye disease. This chart reflects investor expectations for the company's profitability relative to the sector. It provides insight into how the market views its innovative and minimally invasive technologies.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772644578428 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Sight Sciences develops and markets medical devices for the treatment of glaucoma and dry eye disease. Amidst the general market fluctuations shown by this chart, Sight Sciences' business is driven by demographics and innovation. An aging population is increasing the number of patients, and the company's success depends on the acceptance of its new technologies by surgeons and coverage by insurance companies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772644578496 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Sight Sciences Inc.
Sight Sciences is a medical technology company developing solutions for glaucoma and dry eye diseases. Its innovative products offer new approaches to treating common ophthalmological conditions. This chart shows the company's financial performance as it commercializes its technologies.
Profit of companies in the market segment - Specialized medical equipment
Sight Sciences develops and commercializes technologies for the treatment of glaucoma and dry eye diseases. This chart shows profitability in the ophthalmology equipment sector. For SGHT, this reflects the need for new, minimally invasive treatments for common eye diseases, a huge and growing market.
Overall market profit
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and dry eye diseases. Its products offer minimally invasive solutions. The company's growth depends on the adoption of its technologies by ophthalmologists. This overall profitability chart is not affected by specific trends in the medical technology sector, such as an aging population.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Sight Sciences Inc.
Sight Sciences is a company that produces medical devices for the treatment of the most common eye diseases: glaucoma and dry eye disease. The revenue forecast presented here reflects expectations for the adoption of its minimally invasive OMNI and TearCare technologies by ophthalmologists. This is a bet on new approaches to treating eye diseases.
%20profit%20of%20the%20company%20Sight%20Sciences%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Sight-Sciences-Inc.&v=1772644578589 "Graph of future (projected) profit of the company Sight Sciences Inc.")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Sight Sciences develops and markets medical devices for the treatment of glaucoma and dry eye disease. The revenue forecast for this ophthalmology sector depends on demographic trends (such as an aging population) and the introduction of new minimally invasive procedures. This chart reflects analysts' expectations for growth in the treatment market for common eye diseases.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772644578617 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Sight Sciences develops and markets medical devices for the treatment of glaucoma and dry eye diseases. The company's growth depends on the adoption of its technologies by ophthalmologists. Market revenue projections shown here impact healthcare budgets and consumer spending on healthcare services.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772644578637 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Sight Sciences Inc.
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and ocular surface diseases. This chart shows how the market values its revenue in the competitive ophthalmology sector. This value depends on the acceptance of its technologies by surgeons and adequate insurance reimbursement.
P/S market segment - Specialized medical equipment
Sight Sciences is a company specializing in medical devices for the treatment of glaucoma and dry eye disease, two of the most common ophthalmological conditions. This chart shows the average revenue estimate for the sector, helping to understand how the market views Sight Sciences' innovative products and commercial potential.
P/S of the market as a whole
Sight Sciences is a company specializing in the development and commercialization of medical devices for the treatment of glaucoma and dry eye diseases. Its products offer minimally invasive solutions. This chart provides a general market backdrop for assessing investor sentiment regarding revenue prospects in the niche but growing ophthalmology sector.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Sight Sciences Inc.
Sight Sciences develops and markets medical devices for the treatment of glaucoma and ocular surface diseases. This chart shows how investors estimate the company's future sales. It reflects the demand for innovative and minimally invasive treatments for common ophthalmological conditions.
%20P%2FS%20Sight%20Sciences%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Sight-Sciences-Inc.&v=1772644578809 "The graph of the company's future (projected) P/S Sight Sciences Inc.")
Future (projected) P/S of the market segment - Specialized medical equipment
Sight Sciences develops and markets medical devices for the treatment of glaucoma and dry eye diseases. Its products offer minimally invasive treatment options. This chart reflects how investors view its innovative technologies and their potential to capture share in the large ophthalmology market.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772644578912 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and dry eye diseases. Their growth depends on the adoption of their surgical technologies. This chart, reflecting the state of the healthcare system, is important. Economic stability allows ophthalmology clinics to invest in new equipment and offer patients innovative treatments.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772644578951 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Sight Sciences Inc.
Sight Sciences is a medical device company that develops and markets devices for the treatment of glaucoma and dry eye disease, two of the most common ophthalmological conditions. This chart shows revenue from sales of its innovative surgical and non-surgical systems. Revenue growth reflects the adoption of its technologies in ophthalmological practice.
Sales of companies in the market segment - Specialized medical equipment
Sight Sciences is a medical device company developing innovative approaches to treating two common eye diseases: glaucoma and dry eye disease. Their minimally invasive technologies target the root causes of these conditions. Their revenue is generated through sales of surgical and non-surgical devices.
Overall market sales
Sight Sciences is a company focused on the development and commercialization of medical devices for the treatment of glaucoma and ocular surface diseases. Its products offer minimally invasive treatment options. This total revenue chart includes the healthcare sector, where SGHT strives to improve ophthalmological care standards with its innovative technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Sight Sciences Inc.
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and dry eye disease, two of the most common ophthalmological conditions. This chart shows analysts' expectations for the adoption of its minimally invasive technologies in ophthalmological practice.
%20sales%20of%20the%20company%20Sight%20Sciences%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Sight-Sciences-Inc.&v=1772644579089 "Schedule of future (projected) sales of the company Sight Sciences Inc.")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Sight Sciences develops and markets medical devices for the treatment of the most common eye diseases: glaucoma and dry eye disease. This chart shows forecasts for the entire ophthalmology equipment market. It reflects the growing demand for minimally invasive treatments driven by an aging population and the prevalence of these diseases.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772644579112 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Sight Sciences, a company developing devices to treat glaucoma and dry eye disease, sees this chart as a reflection of demographic trends and the state of healthcare. Rising overall economic forecasts provide funding for the implementation of minimally invasive technologies. An aging population creates a constant demand for effective treatments for eye diseases.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772644579157 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Sight Sciences Inc.
Sight Sciences is a company specializing in medical devices for the treatment of glaucoma and dry eye diseases. Its financial success depends on the acceptance of its technologies by surgeons and insurance reimbursement. This chart shows how the company balances commercialization and research expenses with growing sales revenue.
Market segment marginality - Specialized medical equipment
Sight Sciences is a medical device company focused on the treatment of glaucoma and dry eye diseases. This indicator reflects the commercial success of its minimally invasive technologies. This high result indicates the growing acceptance of its products by physicians and patients.
Market marginality as a whole
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and dry eye diseases. Its growth depends on the adoption of its technologies by surgeons and ophthalmologists. This overall revenue chart does not reflect the specifics of the ophthalmology market, where clinical data and innovation are crucial.
Employees in the company, segment and market as a whole
Number of employees in the company Sight Sciences Inc.
Sight Sciences is a medical technology company focused on treating the underlying causes of glaucoma and dry eye disease. This graphic shows the team developing and commercializing minimally invasive surgical devices, offering new, more gentle approaches to treating common ophthalmological conditions.
Share of the company's employees Sight Sciences Inc. within the market segment - Specialized medical equipment
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and dry eye, two of the most common ophthalmological conditions. Promoting innovative products to physicians requires a strong sales and clinical support team. This chart illustrates its growing influence in ophthalmology through its staff.
Number of employees in the market segment - Specialized medical equipment
Sight Sciences is a medical device company that develops and markets devices for the treatment of glaucoma and dry eye, two of the most common ophthalmological conditions. This graphic shows the team creating innovative and minimally invasive solutions that help preserve vision and improve quality of life for millions of patients.
Number of employees in the market as a whole
Sight Sciences, Inc. is a company developing innovative devices for the treatment of glaucoma and dry eye diseases. The overall economic situation, reflected in the employment graph, impacts the availability of their technologies. A stable labor market provides patients with health insurance, making Sight Sciences' advanced surgical and therapeutic solutions more accessible.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Sight Sciences Inc. (SGHT)
Sight Sciences, Inc. is a company developing devices to treat glaucoma and dry eye disease. This chart illustrates their MedTech model. The per-employee capitalization reflects the high value of their proprietary technologies, but also the costs of clinical research, manufacturing, and building a sales network to reach ophthalmologists.
%20of%20the%20company%20Sight%20Sciences%20Inc.%20(SGHT)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Sight-Sciences-Inc.-SGHT&v=1772644579643 "Chart of market capitalization per employee (in thousands of dollars) of the company Sight Sciences Inc. (SGHT)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Sight Sciences develops and commercializes ophthalmic devices for the treatment of glaucoma and dry eye diseases. In the medical device sector, innovation and patents are key value drivers. This chart shows how the market values its technology portfolio per employee compared to its peers.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772644579753 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and ocular surface diseases. In ophthalmology, this indicator reflects the innovativeness of its products. It demonstrates how the company strives to change the standard of treatment by offering minimally invasive solutions that generate high value.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772644579767 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Sight Sciences Inc. (SGHT)
Sight Sciences is a medical device company developing devices for the treatment of glaucoma (OMNI) and dry eye syndrome (TearCare). This chart shows how the company commercializes its innovations. This is a high-margin business, where efficiency depends on the ability of R&D to create patented products and the sales team to train surgeons in their use.
%20Chart%20Sight%20Sciences%20Inc.%20(SGHT)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Sight-Sciences-Inc.-SGHT&v=1772644579852 "Company Profit Per Employee (in thousands of dollars) Chart Sight Sciences Inc. (SGHT)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Sight Sciences develops and commercializes medical devices for the treatment of glaucoma and dry eye syndrome. Their products (OMNI, TearCare) offer minimally invasive solutions. This chart represents an industry benchmark. In ophthalmology, it reflects how successfully Sight Sciences' team (R&D, sales) convinces surgeons to use their innovative, yet still new, technologies.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772644579865 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Sight Sciences (SGHT) is a company that produces medical devices for the treatment of glaucoma and dry eye. Their key products (OMNI, TearCare) are minimally invasive procedures. They operate under a "razor and blade" model. This chart shows how successful their sales team is in convincing ophthalmic surgeons to use their technologies, leading to increased sales of disposables.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772644579892 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Sight Sciences Inc. (SGHT)
Sight Sciences is a company that produces medical devices for the treatment of glaucoma and dry eye diseases. This chart shows the commercialization of its innovative technologies. The growth in revenue per employee reflects the growing adoption by surgeons of its OMNI and TearCare systems, which offer new approaches to treating common eye diseases.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Sight-Sciences-Inc.-SGHT&v=1772644579907 "Sales chart per company employee Sight Sciences Inc. (SGHT)")
Sales per employee in the market segment - Specialized medical equipment
Sight Sciences (SGHT) is a medical technology company focused on treating glaucoma and dry eye disease. They produce minimally invasive devices. This chart shows how productive their model (R&D, manufacturing, and sales to physicians) is. It compares their revenue per employee to the industry average.
Sales per employee for the market as a whole
Sight Sciences is a medical device company focused on treating eye diseases, primarily glaucoma. They produce surgical instruments (OMNI) and devices for dry eye treatment. This chart shows how their R&D and sales teams monetize these niche ophthalmology products.
Short shares by company, segment and market as a whole
Shares shorted by company Sight Sciences Inc. (SGHT)
Sight Sciences (SGHT) is a company developing ophthalmology medical devices, specifically devices for microinvasive glaucoma surgery (MIGS) and dry eye treatment. This chart shows bearish bets. The rise in shorts may reflect concerns about changes in insurance coverage for their procedures or intense competition in the glaucoma treatment market.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Sight-Sciences-Inc.-SGHT&v=1772644579995 "Short Shares Chart for the Company Sight Sciences Inc. (SGHT)")
Shares shorted by market segment - Specialized medical equipment
Sight Sciences (SGHT) is a company that produces medical devices for treating eye diseases, specifically glaucoma (OMNI) and dry eye syndrome (TearCare). This chart reflects the overall sentiment in the medical device sector, showing how many investors doubt the commercial success of their technologies.
Shares shorted by the overall market
Sight Sciences develops medical devices for the treatment of eye diseases, many of which are non-emergency. When this indicator shows rising fear, it means investors are anticipating a recession. In such a situation, patients tend to postpone "elective" surgeries to save money, which directly reduces demand for Sight Sciences' products.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Sight Sciences Inc. (SGHT)
Sight Sciences is a medical technology company specializing in devices for treating glaucoma and dry eye. Their success depends on surgeon adoption of the technology and, more importantly, Medicare rates. This chart measures how investors are reacting to this news, showing peaks of optimism (overbought) or fear (oversold).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Sight-Sciences-Inc.-SGHT&v=1772644580158 "RSI 14 indicator chart for the company's stock Sight Sciences Inc. (SGHT)")
RSI 14 Market Segment - Specialized medical equipment
Sight Sciences develops and commercializes innovative devices for the treatment of the most common eye diseases—glaucoma (OMNI) and dry eye disease (TearCare). This chart measures the overall momentum in the ophthalmic medical device sector and helps assess whether this niche segment is overheated.
RSI 14 for the overall market
For Sight Sciences, whose devices treat glaucoma, this chart is an indicator of elective surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people, fearing loss of insurance, postpone "non-urgent" surgeries.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast SGHT (Sight Sciences Inc.)
Sight Sciences is an ophthalmology company. It produces the OMNI surgical system (for glaucoma treatment) and the TearCare device (for dry eye syndrome). This chart shows the average analyst price target, which is highly dependent on adoption rates and insurance reimbursement (Medicare).
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-SGHT-Sight-Sciences-Inc.&v=1772644580257 "A chart showing analyst consensus forecasts for the expected stock price. SGHT (Sight Sciences Inc.)")
The difference between the consensus estimate and the actual stock price SGHT (Sight Sciences Inc.)
Sight Sciences is a medtech company focused on treating glaucoma and dry eye disease. Their products (OMNI, TearCare) are devices for minimally invasive surgical procedures (MIGS). This chart shows how confident analysts are in their ability to achieve broad insurance reimbursement for these new procedures.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-SGHT-Sight-Sciences-Inc.&v=1772644580301 "A chart showing the difference between the consensus forecast and the actual stock price. SGHT (Sight Sciences Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Sight Sciences (SGHT) is a company focused on treating two of the most common eye conditions: glaucoma (OMNI system) and dry eye syndrome (TearCare). This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe the ophthalmology market will grow.
Analysts' consensus forecast for the overall market share price
Sight Sciences is a company developing medical devices for the treatment of eye diseases: surgical (OMNI) and non-surgical (TearCare) solutions for glaucoma and dry eye. This chart shows the overall market sentiment. For Sight Sciences, as a medtech company dependent on the implementation of new technologies, overall optimism is important for funding and convincing physicians and insurers.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Sight Sciences Inc.
Sight Sciences is a MedTech company attacking two major eye conditions: glaucoma (MIGS) and dry eye. Their systems (OMNI, TearCare) are minimally invasive tools for doctors. This chart is a summary indicator of their commercialization, reflecting their ability to convince doctors to use their technology and their difficult battle to obtain reimbursement from insurance companies.
AKIMA Market Segment Index - Specialized medical equipment
Sight Sciences is a company that develops medical devices for the treatment of eye diseases, specifically glaucoma and dry eye syndrome. This chart shows the average index for the specialized medical devices sector. It helps investors assess how Sight Sciences' innovative products compare to the industry average.
The AKIM Index for the overall market
Sight Sciences is an ophthalmology company developing devices for the treatment of glaucoma and dry eye. This chart, reflecting the market average, provides context. It helps assess how this growth story in the competitive ophthalmic surgery sector compares to overall macroeconomic trends.
